MWNA
VPHM

Marshall Wace North America’s VIROPHARMA INC VPHM Stock Holding History

Marshall Wace North America’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$4.73M Buy
+94,924
New +$4.24M 0.1% 193

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace North America's VPHM Position: Q4 2013 in Review

Marshall Wace North America opened a new position in VIROPHARMA INC (VPHM) in Q4 2013: 94,924 shares worth $4.73M. The stake represents 0.1% of the portfolio and ranks #193 among its holdings.

172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

  • Marshall Wace North America held 94,924 shares of VIROPHARMA INC worth $4.73M as of Q4 2013.
  • VIROPHARMA INC was a new Marshall Wace North America position in Q4 2013.
  • VIROPHARMA INC made up 0.1% of Marshall Wace North America's portfolio in Q4 2013, its #193 holding.
  • 172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.